259 related articles for article (PubMed ID: 23837856)
1. Nanoengineering approaches to the design of artificial antigen-presenting cells.
Sunshine JC; Green JJ
Nanomedicine (Lond); 2013 Jul; 8(7):1173-89. PubMed ID: 23837856
[TBL] [Abstract][Full Text] [Related]
2. Nanoscale artificial antigen presenting cells for cancer immunotherapy.
Rhodes KR; Green JJ
Mol Immunol; 2018 Jun; 98():13-18. PubMed ID: 29525074
[TBL] [Abstract][Full Text] [Related]
3. PEGylated and CD47-conjugated nanoellipsoidal artificial antigen-presenting cells minimize phagocytosis and augment anti-tumor T-cell responses.
Song S; Jin X; Zhang L; Zhao C; Ding Y; Ang Q; Khaidav O; Shen C
Int J Nanomedicine; 2019; 14():2465-2483. PubMed ID: 31040669
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable Cationic Polymer Blends for Fabrication of Enhanced Artificial Antigen Presenting Cells to Treat Melanoma.
Rhodes KR; Isser A; Hickey JW; Ben-Akiva E; Meyer RA; Kosmides AK; Livingston NK; Tzeng SY; Schneck JP; Green JJ
ACS Appl Mater Interfaces; 2021 Feb; 13(7):7913-7923. PubMed ID: 33573372
[TBL] [Abstract][Full Text] [Related]
5. Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells.
Sunshine JC; Perica K; Schneck JP; Green JJ
Biomaterials; 2014 Jan; 35(1):269-277. PubMed ID: 24099710
[TBL] [Abstract][Full Text] [Related]
6. Biologically Inspired Design of Nanoparticle Artificial Antigen-Presenting Cells for Immunomodulation.
Hickey JW; Vicente FP; Howard GP; Mao HQ; Schneck JP
Nano Lett; 2017 Nov; 17(11):7045-7054. PubMed ID: 28994285
[TBL] [Abstract][Full Text] [Related]
7. Linking form to function: Biophysical aspects of artificial antigen presenting cell design.
Perica K; Kosmides AK; Schneck JP
Biochim Biophys Acta; 2015 Apr; 1853(4):781-90. PubMed ID: 25200637
[TBL] [Abstract][Full Text] [Related]
8. Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma.
Sahin A; Sanchez C; Bullain S; Waterman P; Weissleder R; Carter BS
PLoS One; 2018; 13(7):e0199414. PubMed ID: 29975720
[TBL] [Abstract][Full Text] [Related]
9. Particle-Based Artificial Antigen-Presenting Cell Systems for T Cell Activation in Adoptive T Cell Therapy.
Hou F; Guo Z; Ho MT; Hui Y; Zhao CX
ACS Nano; 2024 Mar; 18(12):8571-8599. PubMed ID: 38483840
[TBL] [Abstract][Full Text] [Related]
10. Rapid Expansion of Highly Functional Antigen-Specific T Cells from Patients with Melanoma by Nanoscale Artificial Antigen-Presenting Cells.
Ichikawa J; Yoshida T; Isser A; Laino AS; Vassallo M; Woods D; Kim S; Oelke M; Jones K; Schneck JP; Weber JS
Clin Cancer Res; 2020 Jul; 26(13):3384-3396. PubMed ID: 32241816
[TBL] [Abstract][Full Text] [Related]
11. Biomimetic Magnetosomes as Versatile Artificial Antigen-Presenting Cells to Potentiate T-Cell-Based Anticancer Therapy.
Zhang Q; Wei W; Wang P; Zuo L; Li F; Xu J; Xi X; Gao X; Ma G; Xie HY
ACS Nano; 2017 Nov; 11(11):10724-10732. PubMed ID: 28921946
[TBL] [Abstract][Full Text] [Related]
12. Generation of Antitumor T Cells For Adoptive Cell Therapy With Artificial Antigen Presenting Cells.
Shrestha B; Zhang Y; Yu B; Li G; Boucher JC; Beatty NJ; Tsai HC; Wang X; Mishra A; Sweet K; Lancet JE; Kelley L; Davila ML
J Immunother; 2020 Apr; 43(3):79-88. PubMed ID: 31834208
[TBL] [Abstract][Full Text] [Related]
13. Artificial antigen-presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4(+) T cells.
Garnier A; Hamieh M; Drouet A; Leprince J; Vivien D; Frébourg T; Le Mauff B; Latouche JB; Toutirais O
Immunol Cell Biol; 2016 Aug; 94(7):662-72. PubMed ID: 26924643
[TBL] [Abstract][Full Text] [Related]
14. A novel system of artificial antigen-presenting cells efficiently stimulates Flu peptide-specific cytotoxic T cells in vitro.
Han H; Peng JR; Chen PC; Gong L; Qiao SS; Wang WZ; Cui ZQ; Yu X; Wei YH; Leng XS
Biochem Biophys Res Commun; 2011 Aug; 411(3):530-5. PubMed ID: 21756876
[TBL] [Abstract][Full Text] [Related]
15. Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells.
Latouche JB; Sadelain M
Nat Biotechnol; 2000 Apr; 18(4):405-9. PubMed ID: 10748520
[TBL] [Abstract][Full Text] [Related]
16. Cell-Sized Lipid Vesicles as Artificial Antigen-Presenting Cells for Antigen-Specific T Cell Activation.
Chen JY; Agrawal S; Yi HP; Vallejo D; Agrawal A; Lee AP
Adv Healthc Mater; 2023 May; 12(12):e2203163. PubMed ID: 36645182
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of T-Cell Activation by Oscillatory Forces and Engineered Antigen-Presenting Cells.
Majedi FS; Hasani-Sadrabadi MM; Thauland TJ; Li S; Bouchard LS; Butte MJ
Nano Lett; 2019 Oct; 19(10):6945-6954. PubMed ID: 31478664
[TBL] [Abstract][Full Text] [Related]
18. DNA Engineered Lymphocyte-Based Homologous Targeting Artificial Antigen-Presenting Cells for Personalized Cancer Immunotherapy.
Sun L; Shen F; Xiong Z; Yang H; Dong Z; Xiang J; Gu Q; Ji Q; Fan C; Liu Z
J Am Chem Soc; 2022 May; 144(17):7634-7645. PubMed ID: 35438987
[TBL] [Abstract][Full Text] [Related]
19. Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes.
Ye Q; Loisiou M; Levine BL; Suhoski MM; Riley JL; June CH; Coukos G; Powell DJ
J Transl Med; 2011 Aug; 9():131. PubMed ID: 21827675
[TBL] [Abstract][Full Text] [Related]
20. Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules.
Suhoski MM; Golovina TN; Aqui NA; Tai VC; Varela-Rohena A; Milone MC; Carroll RG; Riley JL; June CH
Mol Ther; 2007 May; 15(5):981-8. PubMed ID: 17375070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
